Beyond these interactions, GAS5 directly modulates the activity of subsequent genetic targets, such as binding to the insulin receptor (IR) promoter to regulate its expression and promoting apoptosis in bladder cancer cells by downregulating the transcription of enhancer of zeste homolog 2 (EZH2) [40,49]. Here, EZH2 is linked to urinary bladder cancer.